V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10443957 | 10033704 | null | 71 | Adjuvant (A) | 2018-08-22 | 2018-08-22 | Rituximab | 02 | N | RITUXIMAB | 101754682 |
| 10443967 | 10033705 | 1.72 | 60 | Curative (C) | null | 2016-07-26 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 101191083 |
| 10443995 | 10033706 | null | 86.1 | null | 2019-09-12 | 2019-10-04 | Docetaxel | 02 | null | DOCETAXEL | 101192736 |
| 10444007 | 10033707 | 1.77 | 81.5 | Curative (C) | 2021-03-12 | 2021-04-03 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101541952 |
| 10444028 | 10033708 | 1.6 | 47.5 | 03 | 2019-11-01 | 2019-11-05 | CHOP R - 21 days | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100845782 |
| 10444030 | 10033709 | 1.53 | 90.7 | Palliative (P) | 2020-02-15 | 2020-02-22 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101831536 |
| 10444041 | 10033710 | 1.69 | 69.2 | 03 | 2019-04-09 | 2019-04-23 | Rituximab | 02 | N | RITUXIMAB | 100241635 |
| 10444044 | 10033711 | 1.61 | 79 | Not known (9) | 2016-08-12 | 2019-08-26 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100654745 |
| 10444049 | 10033712 | 1.8 | 77.3 | Palliative (P) | 2016-09-03 | 2016-09-25 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101405700 |
| 10444051 | 10033713 | null | 82.2 | Palliative (P) | 2020-03-29 | 2020-04-17 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100041152 |
| 10444058 | 10033714 | 1.84 | 87.6 | Adjuvant (A) | 2018-02-28 | 2018-03-02 | Rituximab | 02 | N | RITUXIMAB | 100237247 |
| 10444072 | 10033715 | 1.71 | 68.6 | Palliative (P) | 2020-11-21 | 2020-11-21 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 101503187 |
| 10444075 | 10033716 | 1.68 | 81.3 | Disease modification (D) | 2021-06-03 | 2021-06-03 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100705279 |
| 10444079 | 10033717 | 1.5 | 83.1 | Curative (C) | 2016-03-21 | 2016-03-21 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101420715 |
| 10444081 | 10033718 | 1.53 | 0 | null | 2019-08-03 | 2019-08-10 | Rituximab | 02 | null | RITUXIMAB | 101026113 |
| 10444092 | 10033719 | 1.71 | 90.4 | Palliative (P) | 2017-07-05 | 2017-07-08 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101402593 |
| 10444099 | 10033720 | 1.57 | null | Palliative (P) | 2019-07-11 | 2019-07-11 | IBRUTINIB | 02 | N | IBRUTINIB | 100789486 |
| 10444105 | 10033721 | 1.67 | 74.4 | Palliative (P) | 2015-03-11 | 2015-03-28 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100768400 |
| 10444112 | 10033722 | 1.7 | 0 | Adjuvant (A) | 2017-06-29 | 2017-06-29 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100940863 |
| 10444116 | 10033723 | 1.8 | 97 | Curative (C) | 2019-09-15 | 2019-10-17 | CAPECITABINE + OXALIPLATIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101394731 |
| 10444121 | 10033724 | 1.8 | 71.2 | 03 | 2015-08-19 | 2015-08-25 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101140500 |
| 10444139 | 10033725 | 1.8 | 159.9 | null | 2022-05-06 | 2022-05-21 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101172040 |
| 10444145 | 10033726 | 0 | 91 | Palliative (P) | 2018-03-10 | 2018-03-10 | IBRUTINIB | 02 | N | IBRUTINIB | 101087555 |
| 10444164 | 10033727 | 1.78 | 85.8 | Neo-adjuvant (N) | 2020-12-23 | 2021-01-22 | Rituximab | 02 | null | RITUXIMAB | 101710017 |
| 10444180 | 10033728 | 0 | 80 | null | 2021-02-27 | 2021-03-14 | CAPECITABINE + OXALIPLATIN | 02 | null | IBRUTINIB | 100923929 |
| 10444222 | 10033729 | 1.74 | 107 | null | 2017-10-01 | 2017-10-27 | Capecitabine + Oxaliplatin 14day | 02 | null | CAPECITABINE + OXALIPLATIN | 100626582 |
| 10444229 | 10033730 | 1.58 | 92 | Curative (C) | null | 2016-08-27 | PEMBROLIZUMAB | 02 | Y | PEMBROLIZUMAB | 100273348 |
| 10444236 | 10033731 | 1.63 | 80 | Palliative (P) | 2018-07-21 | 2018-07-28 | CHOP R | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101682569 |
| 10444239 | 10033732 | 1.84 | 57.5 | Disease modification (D) | 2018-04-14 | 2018-04-14 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 101862582 |
| 10444240 | 10033733 | 1.75 | 90.6 | null | 2020-06-14 | 2020-07-06 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE | 101816857 |
| 10444250 | 10033734 | 1.75 | 112.4 | Palliative (P) | 2016-06-19 | 2016-06-20 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100685824 |
| 10444251 | 10033735 | 1.74 | 60 | Neo-adjuvant (N) | 2018-12-14 | 2018-12-16 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100128939 |
| 10444277 | 10033736 | 1.71 | 95 | Palliative (P) | 2016-02-01 | 2016-02-06 | Capecitabine | 02 | N | CAPECITABINE | 100987212 |
| 10444307 | 10033737 | 1.54 | 60 | Palliative (P) | 2017-11-21 | 2017-11-21 | IBRUTINIB | 02 | N | IBRUTINIB | 101697153 |
| 10444332 | 10033738 | 1.64 | 118 | null | 2019-02-13 | 2019-02-13 | CHOP R | 99 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100239282 |
| 10444350 | 10033739 | 1.69 | 73 | null | 2022-03-31 | 2022-03-31 | CAPECITABINE + OXALIPLATIN | 02 | null | RITUXIMAB | 100066969 |
| 10444410 | 10033741 | 1.5 | 58.2 | Palliative (P) | 2016-08-20 | 2016-08-20 | IBRUTINIB | 02 | N | IBRUTINIB | 100152904 |
| 10444411 | 10033742 | 1.63 | 95 | null | 2020-05-28 | 2020-06-25 | IBRUTINIB | 02 | null | IBRUTINIB | 101728326 |
| 10444417 | 10033743 | 1.72 | 107.2 | Curative (C) | 2020-03-17 | 2020-06-09 | Rituximab | 02 | N | RITUXIMAB | 101843700 |
| 10444472 | 10033744 | 1.79 | 0 | Palliative (P) | 2017-05-05 | 2017-05-10 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101105006 |
| 10444473 | 10033745 | 1.82 | 71 | null | 2019-04-30 | 2019-04-30 | IBRUTINIB | N | N | IBRUTINIB | 101370773 |
| 10444483 | 10033746 | 1.55 | 76 | Palliative (P) | 2016-11-19 | 2016-11-30 | Capecitabine + Oxaliplatin 21day | 02 | Y | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101462660 |
| 10444497 | 10033747 | 1.74 | 86.5 | Palliative (P) | 2018-06-19 | 2018-07-05 | Rituximab | 02 | N | RITUXIMAB | 100060768 |
| 10444531 | 10033748 | 1.66 | 77.7 | Palliative (P) | 2021-04-05 | 2021-04-05 | IBRUTINIB | 02 | N | IBRUTINIB | 101009678 |
| 10444559 | 10033749 | 1.53 | 90 | null | 2012-10-27 | 2016-07-02 | IBRUTINIB | 02 | null | IBRUTINIB | 101865438 |
| 10444561 | 10033750 | 1.65 | 93 | Palliative (P) | 2019-10-06 | 2019-10-06 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101090228 |
| 10444563 | 10033751 | 1.74 | 87 | Palliative (P) | 2022-04-21 | 2022-04-30 | Rituximab | 02 | N | RITUXIMAB | 101375832 |
| 10444564 | 10033752 | 1.71 | 87 | Curative (C) | 2016-12-21 | 2017-01-03 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100550798 |
| 10444565 | 10033753 | 1.59 | 73.6 | Curative (C) | 2016-04-27 | 2016-10-02 | Docetaxel | 02 | N | DOCETAXEL | 100086892 |
| 10444568 | 10033754 | 1.6 | 48.7 | Adjuvant (A) | 2020-01-21 | 2020-02-17 | Docetaxel | 02 | null | DOCETAXEL | 100945896 |